INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,752 | -9.7% | 264,000 | +9.8% | 0.02% | +4.5% |
| Q2 2023 | $15,228 | -99.3% | 240,500 | +58.9% | 0.02% | +1000.0% |
| Q1 2020 | $2,327,000 | +117.9% | 151,400 | +84.0% | 0.00% | +100.0% |
| Q2 2019 | $1,068,000 | +4.5% | 82,300 | -1.9% | 0.00% | 0.0% |
| Q1 2019 | $1,022,000 | -35.8% | 83,900 | -40.0% | 0.00% | -50.0% |
| Q4 2018 | $1,592,000 | +58.1% | 139,800 | +201.3% | 0.00% | +100.0% |
| Q3 2018 | $1,007,000 | -94.2% | 46,400 | -94.7% | 0.00% | -88.9% |
| Q2 2018 | $17,223,000 | +50.1% | 870,476 | +59.7% | 0.01% | -30.8% |
| Q1 2018 | $11,472,000 | +37.7% | 545,000 | -5.3% | 0.01% | +44.4% |
| Q4 2017 | $8,330,000 | +31.5% | 575,300 | +43.3% | 0.01% | +28.6% |
| Q3 2017 | $6,337,000 | +103.6% | 401,600 | +60.3% | 0.01% | +75.0% |
| Q2 2017 | $3,112,000 | -30.6% | 250,600 | -9.2% | 0.00% | -33.3% |
| Q1 2017 | $4,485,000 | -31.0% | 276,000 | +18.0% | 0.01% | -50.0% |
| Q1 2016 | $6,502,000 | +170.5% | 233,900 | +423.3% | 0.01% | +140.0% |
| Q4 2015 | $2,404,000 | -67.2% | 44,700 | -75.6% | 0.01% | -70.6% |
| Q3 2015 | $7,331,000 | +613.8% | 183,091 | +325.8% | 0.02% | +750.0% |
| Q1 2015 | $1,027,000 | – | 43,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |